ATE309261T1 - Trizyklisch-monosaccharid-derivative verwendbar bei der behandlung von akuten ischamisch- induzierten neurodegenerationen - Google Patents

Trizyklisch-monosaccharid-derivative verwendbar bei der behandlung von akuten ischamisch- induzierten neurodegenerationen

Info

Publication number
ATE309261T1
ATE309261T1 AT00950475T AT00950475T ATE309261T1 AT E309261 T1 ATE309261 T1 AT E309261T1 AT 00950475 T AT00950475 T AT 00950475T AT 00950475 T AT00950475 T AT 00950475T AT E309261 T1 ATE309261 T1 AT E309261T1
Authority
AT
Austria
Prior art keywords
trizyclic
treatment
acute ischemic
monosaccharide derivatives
derivatives usable
Prior art date
Application number
AT00950475T
Other languages
English (en)
Inventor
Michael Costanzo
Bruce E Maryanoff
Richard P Shank
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE309261T1 publication Critical patent/ATE309261T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT00950475T 1999-07-26 2000-07-20 Trizyklisch-monosaccharid-derivative verwendbar bei der behandlung von akuten ischamisch- induzierten neurodegenerationen ATE309261T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14561899P 1999-07-26 1999-07-26
PCT/US2000/019800 WO2001007453A1 (en) 1999-07-26 2000-07-20 Tricyclic monosaccharide derivatives useful in treating acute ischemia-induced neurodegeneration

Publications (1)

Publication Number Publication Date
ATE309261T1 true ATE309261T1 (de) 2005-11-15

Family

ID=22513879

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00950475T ATE309261T1 (de) 1999-07-26 2000-07-20 Trizyklisch-monosaccharid-derivative verwendbar bei der behandlung von akuten ischamisch- induzierten neurodegenerationen

Country Status (15)

Country Link
US (1) US6495523B1 (de)
EP (1) EP1204669B1 (de)
JP (1) JP2003505465A (de)
AR (1) AR030912A1 (de)
AT (1) ATE309261T1 (de)
AU (1) AU775296B2 (de)
CA (1) CA2380208A1 (de)
CY (1) CY1105359T1 (de)
DE (1) DE60023910T2 (de)
DK (1) DK1204669T3 (de)
ES (1) ES2252033T3 (de)
MX (1) MXPA02000924A (de)
NZ (1) NZ516783A (de)
TW (1) TW559558B (de)
WO (1) WO2001007453A1 (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242942A (en) 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates
US5258402A (en) * 1992-06-11 1993-11-02 Mcneil-Ppc, Inc. Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
CA2179733C (en) 1993-12-23 2007-03-27 Michael J. Costanzo Anticonvulsant pseudofructopyranose sulfamates
US5498629A (en) * 1993-12-23 1996-03-12 Ortho Pharmaceutical Corporation Anticonvulsant pseudofructopyranose sulfamates
WO1998000124A1 (en) * 1996-06-28 1998-01-08 Ortho Pharmaceutical Corporation Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of postischemic neurodegeneration
ATE294577T1 (de) * 1999-02-24 2005-05-15 Univ Cincinnati Verwendung von sulfamat derivaten zur behandlung von impulsiven störungen

Also Published As

Publication number Publication date
TW559558B (en) 2003-11-01
US6495523B1 (en) 2002-12-17
AR030912A1 (es) 2003-09-03
WO2001007453A1 (en) 2001-02-01
EP1204669A1 (de) 2002-05-15
DE60023910T2 (de) 2006-07-20
JP2003505465A (ja) 2003-02-12
DE60023910D1 (de) 2005-12-15
EP1204669B1 (de) 2005-11-09
CA2380208A1 (en) 2001-02-01
DK1204669T3 (da) 2006-02-20
ES2252033T3 (es) 2006-05-16
AU6357700A (en) 2001-02-13
CY1105359T1 (el) 2010-03-03
MXPA02000924A (es) 2003-07-14
AU775296B2 (en) 2004-07-29
NZ516783A (en) 2005-03-24

Similar Documents

Publication Publication Date Title
DE60001421D1 (de) Behandlung von abgas
EE200100480A (et) Ksenoon kasutamiseks närvimürgistuste ravis
EE200200251A (et) Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
IS2594B (is) Arýlmetýl-kabónýlamínó-þíasólafleiður og notkun þeirra sem æxlishemjandi efni
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
DE60016672D1 (de) Körpersreinigungsfolie
PT1212317E (pt) Derivados de indole e sua utilizacao no tratamento de osteoporose entre outras aplicacoes
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
DE69918171D1 (de) Wäschebehandlung
EP1117431A4 (de) Behandlung von acidose
ATE298569T1 (de) Virus behandlung
EE200200305A (et) Südame arütmiate ravis kasutatavad uued asabitsüklooktaani derivaadid
NO20013337D0 (no) Ny behandling
PT1152756E (pt) Derivados de anticonvulsivo uteis no tratamento do autismo
DE60023003D1 (de) Haarbehandlungsmittel
DE60026821D1 (de) Behandlung von bohrspülung
DK1228041T3 (da) Indolderivater og anvendelse deraf som SHT2A-ligander
ATE267598T1 (de) Virus behandlung
DE69924008D1 (de) Wäschebehandlung
DE60024095D1 (de) Wasserenthärtungs- und waschmittelzusammensetzungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1204669

Country of ref document: EP

REN Ceased due to non-payment of the annual fee